Continued Pressure for Alveolar Protection (CPAP) Trial is a study to find out if using CPAP (a machine that helps babies breathe) until 34 weeks' PMA (postmenstrual age) or for at least 2 more weeks helps prevent bronchopulmonary dysplasia (a lung problem) or death by 36 weeks' PMA. Babies born before 29 weeks and who meet certain health conditions can join. They need to be stable, using CPAP with specific settings, and have the permission of their parents or guardians. Babies with major health issues, certain conditions, or needing surgery during the study cannot join.
- Length: Study lasts until baby reaches 36 weeks' PMA.
- Visits: Regular check-ups to monitor baby's health.
- Participation: Requires parent's or guardian's consent.